REX American Resources (REX) Stock Quote

Detailed Quote for REX American Resources (REX)

After Hours: $ 27.86

0.00 (0.00%)

Volume: 1.23 k

4:34 PM EST Feb 10, 2012

close 52 Week Information

52 Week High

February 10, 2012

Close: 28.18

52 Week Low

March 11, 2011

Close: 13.355

Today

Last Price
27.86

Change $
0.15

Change %
0.54%

Tick
N/A

Bid
27.66

Bid Size
400

Ask
N/A

Ask Size
0

Open
27.93

High
28.18

Low
27.66

Prev Close
28.01

Last Trade
2/10/12

Volume
34.53 k

52 Wk Hi
28.18

52 Wk Low
13.355

Market Cap
231.85 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
8,321,819

EPS (TTM)
1.43

PE Ratio
19.50

close Exchange Information Listed On New York Stock Exchange (NYE) Exchange
NYE

News and Media for REX American Resources (REX)

Sector News | Topic News

News for REX

Wed, Nov 30, 2011

7:00 AM

REX American Resources' Third Quarter Diluted EPS Rise 59% to $0.70 from $0.44, Reflecting Improved Results from Ethanol Production Interests - Business Wire

Mon, Nov 21, 2011

10:15 AM

REX American Resources to Report Q3 Results and Host Conference Call and Webcast on Wednesday, November 30 - Business Wire

Fri, Nov 21, 2008

5:17 PM

ViRexx Announces Appointment of Directors and Notice of Intention to Make a Proposal to Creditors - Marketwire Canada

Fri, Sep 19, 2008

11:35 AM

ViRexx Announces LM Funds Corp. Excercises Option to Exchange Convertible Loan - Marketwire Canada

Mon, Sep 15, 2008

5:48 PM

ViRexx Announces Failure to Secure an Alternative Equivalent Funder to Replace LM Funds Corp. - Marketwire Canada

Wed, Sep 10, 2008

5:10 PM

ViRexx Announces Results of Rights Offering and Failure of LM Funds Corp. to Provide Standby Commitment - Marketwire Canada

Thu, Aug 28, 2008

7:00 PM

ViRexx Receives Delisting Notification From AMEX Regarding Non-Compliance With Listing Standards - Marketwire Canada

Mon, Aug 18, 2008

5:41 PM

ViRexx Announces Encouraging Results From Its Lead Chimigen(TM) Therapeutic Vaccine Candidate for Treating Chronic Hepatitis B Virus Infections - Marketwire Canada

Thu, Aug 14, 2008

1:23 PM

ViRexx Announces 2008 Second Quarter Results - Marketwire Canada

Fri, Aug 01, 2008

3:36 PM

ViRexx Announces Approvals of Rights Offering - Marketwire Canada

Wed, Jul 16, 2008

5:21 PM

ViRexx Announces Record Date for Rights Offering - Marketwire Canada

Thu, Jul 10, 2008

4:32 PM

ViRexx Announces Filing of Amended and Restated Audited Financial Statements for Year Ended December 31, 2007 and Amended and Restated Annual Report on Form 20-F - Marketwire Canada

Tue, May 13, 2008

10:42 PM

ViRexx Announces 2008 First Quarter Results and Receives Notification of Non-Compliance From the American Stock Exchange - Marketwire Canada

Tue, Apr 08, 2008

1:12 PM

ViRexx Announces Change in Board - Marketwire Canada

Tue, Feb 12, 2008

6:18 PM

ViRexx Announces 2007 Fiscal Year Results - Marketwire Canada

Wed, Dec 05, 2007

11:52 AM

ViRexx Announces Pivotal OvaRex(R) MAb Trial Results Fail to Achieve Statistical Significance - Marketwire Canada

Thu, Nov 15, 2007

2:15 PM

CORRECTION FROM SOURCE: ViRexx Announces Third Quarter Results - Marketwire Canada

Wed, Nov 14, 2007

3:46 PM

ViRexx Announces Third Quarter Results - Marketwire Canada

Wed, Oct 17, 2007

4:58 PM

ViRexx Announces Reconciliation With Sigma Tau - Marketwire Canada

Tue, Oct 16, 2007

12:59 PM

ViRexx Announces Second OvaRex(R) MAb Phase III Trial Reaches 118th Relapse Event - Marketwire Canada

More News for REX >>

Tags for REX American Resources

Research stocks or mutual funds related to REX American Resources by keywords or tags. Find companies that have a similar focus to REX. The keywords below have been associated to REX by either user submission or electronic means.

biotechnology company Viral hepatitis hepatitis b and pregnancy pharmaceutical market generic pharmaceutical hepatitis vaccination biotechnology market pharmaceutical research and development pharmaceutical manufacturing company dupont pharmaceuticals Biological Products pharma marketing pharmaceutical industry marketing pharmaceutical software pharma manufacturing pharmaceutical market share hepatitis vaccine pharma license history of hepatitis b pharmaceutical cro pharma companies pharma consulting toronto stock exchange pharmaceutical sales clinical trials industry hepatitis c incubation period pharmaceutical distributors biotech corporation pharmaceutical development pharmaceutical reports pharmaceutical consultant Drugs stock market investors pharmaceutical industry news investor pharmaceutical manufacturing software hepatitis a treatment stock investor pharmaceutical manufacturing biotech profile stocks contract pharmaceutical pharmaceutical consulting pharmaceutical industry biotech contract treatment for hepatitis b hepatitis hepatitis viruses pharmaceutical advances pharmaceutical distributor